Sort
8,912 grants matching “sars cov 2”
Enabling risk-based testing through characterization of environmentally induced immune dysregulation and susceptibility to the SARS-CoV2 virus and COVID-19
$935,642Florence Burleson · · N01 · FY2022 · ES
PPE Request
$935,415Judith S. Currier · University Of California Los Angeles · S10 · FY2021 · AI
Cell competition in pulmonary fibrosis and ARDS
$934,920Stijn Piet Johan De Langhe · Mayo Clinic Rochester · R35 · FY2024 · HL
Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS
$934,853Dhiraj Kumar Singh · Texas Biomedical Research Institute · R01 · FY2025 · AI
Proteomics Core Facility
$933,647Yan Li · National Institute Of Neurological Disorders And Stroke · ZIC · FY2023 · NS
Alveolus as Incubator: Functional Genomic Dissection of the Host Response to SARS-CoV-2 Infection.
$933,000Anthony W Orvedahl · Washington University · DP2 · FY2024 · AI
Project 1: Serology
$931,365Taia Wang · Stanford University · U54 · FY2020 · CA
English Longitudinal Study of Ageing - Renewal 2024
$931,201Andrew Steptoe · University College London · R01 · FY2024 · AG
Microglia-Amyloid interactions in delirium superimposed on dementia
$930,072Niccolo Terrando · Duke University · R01 · FY2024 · AG
Community-Academic Partnerships to Address COVID-19 Inequities within African American Communities
$930,000Tiarney D Ritchwood · Wake Forest University Health Sciences · DP2 · FY2024 · MD
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)
$929,964Andrew Redd · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
HVTN 405/HPTN 1901 (CoVPN) Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals
$929,677Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Neuroimaging Core
$929,085Peter Thornton Fox · University Of Texas Hlth Science Center · U19 · FY2024 · AG
Microbial Impact on NeuroDegeneration in Alzheimer's Dementia: MIND-AD
$928,646Adam Peter Spira · Johns Hopkins University · R01 · FY2024 · AG
Lung-on-a-Chip Disease Models for Efficacy Testing (COVID-19 Competitive Revision)
$928,351Donald E Ingber · Harvard University · UH3 · FY2020 · HL
Inhibition of COVID-19 associated acute fibrin deposition in lung
$928,309Peter D. Sun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
7HP349, an oral integrin activator to augment effectiveness of pre-exposure influenza vaccination
$928,224Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2023 · AI
Structural vaccinology for infectious diseases
$927,506Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine
$927,069Amit Praful Khandhar · Hdt Bio Corporation · R61 · FY2021 · AI
Technology Core
$925,488William Owen Osburn · Johns Hopkins University · U54 · FY2023 · EB
The Jackson Laboratory Knockout Mouse Production and Phenotyping Project (JAX KOMP2)
$925,466Robert E Braun · Jackson Laboratory · UM1 · FY2020 · OD
COPD(GENE): TASK B: "STEWARDSHIP OF BIOSPECIMEN AND DATA REPOSITORIES"
$925,355James D Crapo · National Jewish Health · N01 · FY2023 · HL
Role of NLRP3 signals in ischemia/reperfusion-induced organ injury
$924,366Dianne B McKay · Scripps Research Institute, The · R01 · FY2022 · DK
Genetic Investigation of Covid 19 in Lung Disease
$922,822Mark L Kahn · University Of Pennsylvania · R01 · FY2022 · HL
COPD(GENE): TASK B: "STEWARDSHIP OF BIOSPECIMEN AND DATA REPOSITORIES"
$922,055James D Crapo · National Jewish Health · N01 · FY2024 · HL